Pepijn Van Houten
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Delivering cytokine mRNA to secondary lymphoid organs for robust cancer immunotherapy.
Journal: Research square
Published: April 03, 2026
Delivering cytokine mRNA to secondary lymphoid organs for robust cancer immunotherapy.
Journal: Research square
Published: April 03, 2026
Clinical actionability of molecular testing in advanced thyroid cancer: a real-world cohort study.
Journal: European thyroid journal
Published: February 24, 2026
Increased cytokine production capacity and persistent inflammation after achieving remission of Cushing's syndrome.
Journal: Journal of clinical & translational endocrinology
Published: January 12, 2026
Prognostic value of volume-based metabolic parameters of [18F]FDG PET/CT in anaplastic thyroid carcinoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 18, 2025
High Local and Systemic Expression of Pentraxin-3 in Anaplastic Thyroid Cancer.
Journal: International journal of molecular sciences
Published: October 29, 2025
Immunomodulatory effects of lenvatinib in patients with advanced thyroid cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: October 10, 2025
Induction of trained immunity in myeloid cells and their progenitors from thyroid cancer patients.
Journal: Frontiers in immunology
Published: September 16, 2025
High recovery rate of adrenal function after successful surgical treatment of Cushing's syndrome.
Journal: Endocrine connections
Published: March 12, 2025
Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey.
Journal: Endocrine connections
Published: February 01, 2024
Last Updated: 09/26/2026